Factors Affecting Maternal Respiratory Syncytial Virus Vaccination and the Impact on Infant Hospitalization During the 2023-2024 Season in Dallas, Texas. [PDF]
Bailey NA, Most ZM.
europepmc +1 more source
The Effectiveness of Respiratory Syncytial Virus Prophylaxis Programme using Palivizumab in Preterm Infants: <i>A single institute retrospective study</i>. [PDF]
Al Mandhari H +5 more
europepmc +1 more source
Bivalent RSV prefusion F vaccination elicits effective neutralization of contemporary and monoclonal antibody-resistant RSV strains. [PDF]
Chen W +14 more
europepmc +1 more source
Estimation of Public Health Impact with Use of Nirsevimab During the 2024-2025 RSV Season in the USA: a Modeling Study. [PDF]
Yarnoff B +11 more
europepmc +1 more source
Real-World Effectiveness of Universal Nirsevimab on Bronchiolitis Incidence: A Regional Hub-Spoke Surveillance Analysis in Liguria, Italy. [PDF]
Mariani M +19 more
europepmc +1 more source
Advances in the prevention of respiratory syncytial virus infection in children. [PDF]
Krey JG +4 more
europepmc +1 more source
Post-acute symptom persistence following SARS-CoV-2, RSV, and influenza in children: A retrospective cohort study. [PDF]
Bedir F, Demir V.
europepmc +1 more source
Real-world impact of nirsevimab immunisation and maternal RSV vaccination against respiratory disease on emergency department attendances and admissions: a multinational retrospective analysis. [PDF]
Perramon-Malavez A +16 more
europepmc +1 more source
Phylodynamics and molecular epidemiology of the respiratory syncytial virus fusion protein in China. [PDF]
Amjad MN +14 more
europepmc +1 more source
Knowledge, attitudes, and practices of pediatricians in Crete, Greece, regarding RSV immunization: a cross-sectional study. [PDF]
Vrentzos D +4 more
europepmc +1 more source

